Inside the labs and clinics where founders, physicians, and researchers are betting their lives on 'solving' ageing.

Pfizer Inc. today announced detailed results from the pivotal Phase 3 TALAPRO-3 study of TALZENNA® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI® ...

Nobody has ever been born in space. More than 600 people have traveled beyond Earth’s atmosphere since Yuri Gagarin first did it in 1961, but not one of them was conceived there, grew there, or came ...

A Texas-based firm, Colossal Biosciences, claims a breakthrough in de-extinction, developing an artificial eggshell system to potentially resurrect the extinct moa. While scientists express skepticism ...

Median overall survival, a secondary endpoint, reached nearly 3.5 years with Johnson & Johnson's RYBREVANT® plus LAZCLUZE® in atypical EGFR-mutated disease Consistent ...